The aim of this study is to compare the effects of ultrasound-guided hydrodissection with 5% dextrose and perineural corticosteroid injection on the clinical parameters of carpal tunnel syndrome, as well as to evaluate the long-term efficacy of these treatments.
Who can participate
Age range20 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients diagnosed with unilateral moderate carpal tunnel syndrome (CTS) confirmed by an electrophysiological study within the last 6 months
* Presence of at least one of the following symptoms lasting more than one month:
* Paresthesia/dysesthesia accompanied by weakness and clumsiness in the hand, worsened by repetitive wrist use or sleep, and relieved by postural correction or shaking of the hand
* Numbness due to sensory disturbance in the median nerve (MN) distribution
* Thenar muscle weakness with atrophy
* Positive Tinel's sign or Phalen's test
* Pain intensity of ≥4 out of 10 on the Visual Analog Scale (VAS) prior to treatment
Exclusion Criteria:
* History of previous wrist surgery, polyneuropathy, brachial plexopathy, or thoracic outlet syndrome
* Presence of systemic infection
* Pregnancy
* Prior corticosteroid injection for CTS
What they're measuring
1
Boston Carpal Tunnel Questionnaire
Timeframe: At baseline, at Month 1,3,6 (Visit 1,2,3)